IQVIA™ Real-World Insights Bibliography

Budget impact analysis of Biphasic Insulin Aspart in the treatment of Type 2 Diabetes Mellitus in Malaysia: A Public Payer Perspective
Author(s): Tan SC1, Matzen P2, Yeo LN2
Affiliations(s): 1 IMS Asia Pacific, Singapore 2 Novo Nordisk Pharma Malysia, Kuala Lumpur, Malaysia
Publication(s):  ISPOR 6th Asia-Pacific Conference, Beijing, China, 6-9 September, 2014
Document Type(s): Poster,
Countries: Malaysia,
C:
Y:
Diabetes,
2014
  L:
A:
English
Budget impact,
  Add to report
 
 
Estimating the Costs of Diabetes Mellitus: An Analysis in Malaysia
Author(s): Todorova L1, Hnoosh A2, Bloomfield E2, Shiu ML3
Affiliations(s): 1 Novo Nordisk International Operations, Zurich, Switzerland 2 IMS Health, London, UK 3 Novo Nordisk Pharma Operations (BAOS) Sdn. Bhd., Kuala Lumpur, Malaysia
Publication(s):  ISPOR 5th Asia-Pacific Conference, 2-4 September 2012, Taipei, Taiwan.
Document Type(s): Abstract,
Countries: Malaysia,
Click here for the abstract
C:
Y:
Diabetes,
2012
  L:
A:
English
Cost analysis,
  Add to report
 
 
The cost-effectiveness of travoprost preserved with polyquad® in newly treated open-angle glaucoma patients in 7 Asian countries.
Author(s): Gerlier L1, Lamotte M1, Caputo J2, Tan R3
Affiliations(s): 1 IMS Health Consulting EMEA, Vilvoorde, Belgium 2 IMS Health Consulting Asia-Pacific, Singapore 3 ALCON, Asia-Pacific, Singapore
Publication(s):  5th ISPOR Asia-Pacific Conference, 2012, September 2-4, Taipei, Taiwan
Document Type(s): Abstract, Poster,
Countries: India, Malaysia, Singapore, South Korea, Thailand,
C:
Y:
Ophthalmology,
2012
  L:
A:
English
Cost effectiveness,
  Add to report
 
 
Medical resource use and associated costs in open-angle glaucoma in 10 Asia-pacific countries.
Author(s): Gerlier L1, Lamotte M1, Caputo J2, Tan R3
Affiliations(s): 1 IMS Health Consulting EMEA, Vilvoorde, Belgium 2 IMS Health Consulting Asia-Pacific, Singapore 3 ALCON, Asia-Pacific, Singapore
Publication(s):  5th ISPOR Asia-Pacific Conference, 2012, September 2-4, Taipei, Taiwan
Document Type(s): Abstract, Poster,
Countries: Australia, China, Hong Kong, India, Malaysia, New Zealand, Singapore, South Korea, Taiwan, Thailand,
C:
Y:
Ophthalmology,
2012
  L:
A:
English
Burden of illness,
  Add to report
 
 
Asthma control and its direct healthcare costs: findings using a derived Asthma Control Test (ACT) score in eight Asia-Pacific areas.
Author(s): Lai CKW1 Kuo S-H2 de Guia T3 Lloyd A4, Williams AE5, Spencer MD5
Affiliations(s): 1 Dept of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong 2 National Taiwan University Hospital, Taipei, Taiwan 3 Philippine Heart Centre, Quezon City, The Philippines 4 Fourth Hurdle Consulting Ltd, London, UK 5 GlaxoSmithKine R&D, Greenford, UK
Publication(s):  European Respiratory Review 2006; 15:(98): 24-29
Document Type(s): Manuscript in preparation,
Countries: China, Hong Kong, Malaysia, Philippines, Singapore, Taiwan, Vietnam,
C:
Y:
Respiratory disease,
2006
  L:
A:
English
Cost of illness,
  Add to report